Singh A. Global burden of five major types of gastrointestinal cancer. Gastroenterol Rev. 2024;19(3):236–54. https://doi.org/10.5114/pg.2024.141834.

Article  CAS  Google Scholar 

Eyck BM, Van Lanschot JJB, Hulshof MCCM, et al. Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial. J Clin Oncol. 2021;39(18):1995–2004. https://doi.org/10.1200/JCO.20.03614.

Article  CAS  PubMed  Google Scholar 

Shapiro J, Van Lanschot JJB, Hulshof MCCM, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol. 2015;16(9):1090–8. https://doi.org/10.1016/S1470-2045(15)00040-6.

Article  PubMed  Google Scholar 

Hoeppner J, Lordick F, Brunner T, et al. ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286). BMC Cancer. 2016;16(1):503. https://doi.org/10.1186/s12885-016-2564-y.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hoeppner J, Brunner T, Schmoor C, et al. Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer. N Engl J Med. 2025;392(4):323–35. https://doi.org/10.1056/NEJMoa2409408.

Article  PubMed  Google Scholar 

Reynolds JV, Preston SR, O’Neill B, et al. Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial. Lancet Gastroenterol Hepatol. 2023;8(11):1015–27. https://doi.org/10.1016/S2468-1253(23)00243-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ando N, Kato H, Igaki H, et al. A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907). Ann Surg Oncol. 2012;19(1):68–74. https://doi.org/10.1245/s10434-011-2049-9.

Article  PubMed  Google Scholar 

Liang Z, Chen T, Li W, et al. Efficacy and safety of neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in locally advanced esophageal cancer: An updated meta-analysis. Med (Baltim). 2024;103(3):e36785. https://doi.org/10.1097/MD.0000000000036785.

Article  CAS  Google Scholar 

Ronellenfitsch U, Friedrichs J, Barbier E, et al. Preoperative Chemoradiotherapy vs Chemotherapy for Adenocarcinoma of the Esophagogastric Junction: A Network Meta-Analysis. JAMA Netw Open. 2024;7(8):e2425581. https://doi.org/10.1001/jamanetworkopen.2024.25581.

Article  PubMed  PubMed Central  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ Published online March. 2021;29:n71. https://doi.org/10.1136/bmj.n71.

Article  Google Scholar 

Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https://doi.org/10.1136/bmj.l4898.

Article  PubMed  Google Scholar 

Klevebro F, Alexandersson von Döbeln G, Wang N, et al. A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction. Ann Oncol. 2016;27(4):660–7. https://doi.org/10.1093/annonc/mdw010.

Article  CAS  PubMed  Google Scholar 

Kato K, Machida R, Ito Y, et al. Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial. Lancet Lond Engl. 2024;404(10447):55–66. https://doi.org/10.1016/S0140-6736(24)00745-1.

Article  CAS  Google Scholar 

Cao XF, He XT, Ji L, Xiao J, Lv J. Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma. Dis Esophagus. 2009;22(6):477–81. https://doi.org/10.1111/j.1442-2050.2008.00910.x.

Article  PubMed  Google Scholar 

Burmeister BH, Thomas JM, Burmeister EA, et al. Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial. Eur J Cancer. 2011;47(3):354–60. https://doi.org/10.1016/j.ejca.2010.09.009.

Article  PubMed  Google Scholar 

Wang H, Tang H, Fang Y, et al. Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial. JAMA Surg. 2021;156(5):444–51. https://doi.org/10.1001/jamasurg.2021.0133.

Article  PubMed  PubMed Central  Google Scholar 

Tang H, Wang H, Fang Y, et al. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: a prospective multicenter randomized clinical trial. Ann Oncol. 2023;34(2):163–72. https://doi.org/10.1016/j.annonc.2022.10.508.

Article  CAS  PubMed  Google Scholar 

von Döbeln GA, Klevebro F, Jacobsen AB, et al. Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial. Dis Esophagus Off J Int Soc Dis Esophagus. 2019;32(2). https://doi.org/10.1093/dote/doy078.

Stahl M, Walz MK, Stuschke M, et al. Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric Junction. J Clin Oncol. 2009;27(6):851–6. https://doi.org/10.1200/JCO.2008.17.0506.

Article  CAS  PubMed  Google Scholar 

Stahl M, Walz MK, Riera-Knorrenschild J, et al. Preoperative chemotherapy versus chemoradiotherapy in locally advanced adenocarcinomas of the oesophagogastric junction (POET): Long-term results of a controlled randomised trial. Eur J Cancer Oxf Engl 1990. 2017;81:183–90. https://doi.org/10.1016/j.ejca.2017.04.027.

Article  CAS  Google Scholar 

Reynolds JV, Preston SR, O’Neill B, et al. Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial. Lancet Gastroenterol Hepatol. 2023;8(11):1015–27. https://doi.org/10.1016/S2468-1253(23)00243-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Csontos A, Fazekas A, Szakó L, et al. Effects of neoadjuvant chemotherapy vs chemoradiotherapy in the treatment of esophageal adenocarcinoma: A systematic review and meta-analysis. World J Gastroenterol. 2024;30(11):1621–35. https://doi.org/10.3748/wjg.v30.i11.1621.

Article  PubMed  PubMed Central  Google Scholar 

Faron M, Cheugoua-Zanetsie M, Tierney J, et al. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma. J Clin Oncol. 2023;41(28):4535–47. https://doi.org/10.1200/JCO.22.02279.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van Hagen P, Hulshof MCCM, van Lanschot JJB, et al. Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer. N Engl J Med. 2012;366(22):2074–84. https://doi.org/10.1056/NEJMoa1112088.

Article  PubMed  Google Scholar 

Al-Batran SE, Homann N, Pauligk C, et al. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial. Lancet. 2019;393(10184):1948–57. https://doi.org/10.1016/S0140-6736(18)32557-1.

Article  PubMed  Google Scholar 

Pabon CM, Spieler B, Li JJ, Ajani J, Hosein PJ, Blum Murphy M. Is it time to retire preoperative radiation for localized esophageal and gastro-esophageal adenocarcinoma? Oncologist. 2025;30(1):oyae371. https://doi.org/10.1093/oncolo/oyae371.

Article  PubMed  PubMed Central  Google Scholar 

Joshi SS, Badgwell BD. Current treatment and recent progress in gastric cancer. CA Cancer J Clin. 2021;71(3):264–79. https://doi.org/10.3322/caac.21657.

Article  PubMed  PubMed Central  Google Scholar